New Delhi (Sputnik) — India's Directorate-General of Antidumping and Allied Duties (DGAD) said it has established that the domestic chemical industry has suffered a 'material injury' due to imports of Ofloxacin Acid, which is used by pharmaceuticals. It went on to recommend an antidumping duty to the tune of US $4.16 to US$8.55 per kilogram of the chemical.
"The Authority considers it necessary to recommend imposition of a definitive anti-dumping duty on imports of subject goods from the subject country for three years," the DGAD said in a notification.
India imports most of its raw materials for medicine from China, Germany, the US, Italy, and Singapore. "Most of the imports of the Bulk Drugs/Active Pharmaceutical Ingredients (APIs) being done in the country are because of economic considerations. During the year 2016-17, the share of China in the total APIs imported into the country was approximately 66%," according to India's Ministry of Chemicals & Fertilizers.
However, such measures have not deterred the Chinesedragon from expanding its trade in India. China's share in India's total imports during April-August 2017 stood at 16.77%, up 5.2% from the last fiscal. India's total imports since April 2016 — March 2017 were estimated at $384.35 billion, out of which goods worth $61.28 billion came from China.